血液和固体瘤中的双特异性抗体:当前的景观和治疗进展
Lorenzo Guidi1,2, Julian Etessami1,2, Carmine Valenza1,2,3
1Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.
概括
双特异性抗体 (bsAbs) 提供双重向策略,以克服治疗耐药性并提高疗效. 虽然在血液癌症中取得了成功,但固体瘤仍然面临挑战,需要创新的方法来实现更广泛的应用.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 生物技术是生物技术.
背景情况:
- 单克隆抗体由于瘤异质性和耐药性而面临限制.
- 双特异性抗体 (bsAbs) 提供了双重向的方法来克服这些局限性.
- bsAbs通过破坏多个信号通路并优化免疫激活来提高治疗效果.
研究的目的:
- 审查双特异抗体 (bsAbs) 在癌症治疗中的治疗潜力和挑战.
- 突出不同类型的bsAbs.的作用机制.
- 讨论克服固体瘤中bsAbs障碍的策略.
主要方法:
- 关于双特异抗体开发和临床应用的当前文献的综述.
- 分析 bsAbs 参与不同的抗原或途径的机制.
- 检查固体瘤中bsAbs的挑战和创新解决方案.
主要成果:
- bsAbs通过激活T细胞或阻断免疫检查点来证明在血液恶性瘤中的成功.
- 用bsAbs准生长因子或受体氨酸激酶以解决固体瘤中耐药性的问题.
- 临床试验显示有效性,导致批准,许多药物正在开发中.
结论:
- bsAbs代表了癌症治疗的重大进步,提供了持久的反应和改善的免疫激活.
- 克服瘤透和毒性等挑战对于将bsAbs扩展到固体瘤至关重要.
- 结合策略和精确瘤学方法将塑造bsAbs的未来作用.
相关概念视频
Tumor Immunotherapy
411
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
411
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Vaccines
278
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
278
Hybridoma Technology
13.8K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.8K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K


